Viral envelope protein of HTLV-III is the major target antigen for antibodies in hemophiliac patients.
D000914:Antibodies, Viral / Q000032:analysis*; D000956:Antigens, Viral / Q000276:immunology*; D001782:Blood Donors; D017977:Deltaretrovirus / Q000276:immunology*; D005260:Female; D015683:Gene Products, gag; D015483:HIV Antibodies; D015488:HIV Antigens; D006467:Hemophilia A / Q000097:blood / Q000276:immunology*; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D008970:Molecular Weight; D012191:Retroviridae Proteins / Q000276:immunology; D006377:T-Lymphocytes, Helper-Inducer; D050378:T-Lymphocytes, Regulatory; D014759:Viral Envelope Proteins / Q000276:immunology*
D000914:Antibodies, Viral; D000956:Antigens, Viral; D015683:Gene Products, gag; D015483:HIV Antibodies; D015488:HIV Antigens; D012191:Retroviridae Proteins; D014759:Viral Envelope Proteins